## **Core Concept**
Myasthenia gravis (MG) is a chronic autoimmune disorder characterized by weakness and rapid fatigue of the muscles under voluntary control. It is caused by an abnormal immune response that disrupts the communication between nerves and muscles. The disease involves the production of autoantibodies against components of the neuromuscular junction.

## **Why the Correct Answer is Right**
The correct answer, **nicotinic acetylcholine receptor (AChR)**, is the primary target of autoantibodies in myasthenia gravis. These antibodies bind to the AChR at the neuromuscular junction, blocking the action of acetylcholine (ACh), a neurotransmitter that normally binds to AChR to initiate muscle contraction. By blocking AChR, the antibodies reduce the number of available receptors for ACh to bind, thereby impairing the transmission of nerve impulses to muscles and leading to muscle weakness.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While **muscarinic receptors** are also types of acetylcholine receptors, they are primarily involved in the parasympathetic nervous system and are not the target of autoantibodies in myasthenia gravis.
- **Option B:** **Voltage-gated calcium channels** are involved in the release of neurotransmitters, including acetylcholine, but autoantibodies against these channels are associated with Lambert-Eaton myasthenic syndrome (LEMS), a different neuromuscular disorder.
- **Option D:** **Acetylcholinesterase** is the enzyme responsible for breaking down acetylcholine in the synaptic cleft. While autoantibodies against acetylcholinesterase could theoretically exacerbate muscle weakness by preventing the breakdown of ACh and thus prolonging its action, the primary and most well-known autoantibody target in myasthenia gravis is the nicotinic acetylcholine receptor itself.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that about 85% of patients with myasthenia gravis have autoantibodies against the **nicotinic acetylcholine receptor**. The presence of these autoantibodies is a hallmark of the disease and is used as a diagnostic criterion. Patients with myasthenia gravis often show fluctuating muscle weakness that worsens with activity and improves with rest.

## **Correct Answer:** C. nicotinic acetylcholine receptor.